): A drug, Riluzole, which was approved by the Food and Drug Administration 28 years ago to treat amyotrophic lateral sclerosis (aka: ALS or Lou Gehrig’s Disease) was found by a team
of researchers at the University of Houston to preserve nerve cells in patients facing permanent disability or worse from acute spinal cord injuries.
Continue reading…
